These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 16575532)
1. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model. Clavreul A; Delhaye M; Jadaud E; Menei P J Neurooncol; 2006 Aug; 79(1):9-17. PubMed ID: 16575532 [TBL] [Abstract][Full Text] [Related]
2. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression. Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253 [TBL] [Abstract][Full Text] [Related]
3. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699 [TBL] [Abstract][Full Text] [Related]
4. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat. Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768 [TBL] [Abstract][Full Text] [Related]
5. Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model. Ciesielski MJ; Kazim AL; Barth RF; Fenstermaker RA Cancer Immunol Immunother; 2005 Feb; 54(2):107-19. PubMed ID: 15340764 [TBL] [Abstract][Full Text] [Related]
6. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model. Herrlinger U; Aulwurm S; Strik H; Weit S; Naumann U; Weller M J Neurooncol; 2004 Jan; 66(1-2):147-54. PubMed ID: 15015780 [TBL] [Abstract][Full Text] [Related]
7. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1. Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069 [TBL] [Abstract][Full Text] [Related]
8. B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity. Paul DB; Barth RF; Yang W; Shen GH; Kim J; Triozzi PL Gene Ther; 2000 Jun; 7(12):993-9. PubMed ID: 10871746 [TBL] [Abstract][Full Text] [Related]
9. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946 [TBL] [Abstract][Full Text] [Related]
10. Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain. Tseng SH; Hsieh CL; Lin SM; Hwang LH Cancer Gene Ther; 1999; 6(4):302-12. PubMed ID: 10419048 [TBL] [Abstract][Full Text] [Related]
11. Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulating factor and interleukin-12 on established gliomas in rats. Chen JC; Chen Y; Wu JM; Su YH; Tai KF; Tseng SH Cancer Immunol Immunother; 2006 Jul; 55(7):873-83. PubMed ID: 16133106 [TBL] [Abstract][Full Text] [Related]
12. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Tzeng JJ; Barth RF; Orosz CG; James SM Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat. Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964 [TBL] [Abstract][Full Text] [Related]
14. Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors. Agarwalla P; Barnard Z; Fecci P; Dranoff G; Curry WT J Immunother; 2012 Jun; 35(5):385-9. PubMed ID: 22576343 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Yu JS; Burwick JA; Dranoff G; Breakefield XO Hum Gene Ther; 1997 Jun; 8(9):1065-72. PubMed ID: 9189764 [TBL] [Abstract][Full Text] [Related]
16. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604 [TBL] [Abstract][Full Text] [Related]
17. Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors. Eberstål S; Sandén E; Fritzell S; Darabi A; Visse E; Siesjö P Int J Cancer; 2014 Jun; 134(11):2748-53. PubMed ID: 24243648 [TBL] [Abstract][Full Text] [Related]
18. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12. Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617 [TBL] [Abstract][Full Text] [Related]
19. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats. Zhu X; Lu C; Xiao B; Qiao J; Sun Y J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102 [TBL] [Abstract][Full Text] [Related]
20. Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas. Graf MR; Sauer JT; Merchant RE J Neurooncol; 2005 May; 73(1):29-36. PubMed ID: 15933813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]